by EMOL Admin | Nov 1, 2023 | Healthcare Quality
Published in Targeted Oncology (ePub 2023 Nov 1), Trilaciclib Enhances Survival in ES-SCLC,According to Real-World Data, discusses the implications of the findings from data manuallycurated by EMOL Health, in collaboration with Ajeet Gajra, MD, and G1 Therapeutics....
by EMOL Admin | Oct 28, 2023 | Healthcare Quality
EMOL Health, a data aggregation company for community oncology practices, Ajeet Gajra, MD, and G1 Therapeutics presented a poster at the 2023 ASCO Quality Care Symposium in Boston. Myelosuppression and healthcare utilization among patients with chemotherapy-treated...
by EMOL Admin | Oct 19, 2023 | EMOL Partners
EMOL Health would like to congratulate its partner, The National Cancer Treatment Alliance (NCTA), as they launch a nationwide, clinically integrated network (CIN) of leading community oncology practices and pharmacies. Joining the CIN are 43 practices across 24...
by EMOL Admin | Jun 12, 2023 | Technology
The article; Drug Target Identification in Triple Negative Breast Cancer Stem Cell Pathways: A Computational Study of Gene Regulatory Pathways Using Boolean Networks was accepted 31 May 2023, date of publication 6 June 2023. Triple-negative breast cancer (TNBC) is a...
by EMOL Admin | Jan 17, 2019 | EMOL Partners
EMOL Health is pleased to announce a new partnership between EMOL Health and the National Cancer Care Alliance (NCCA). NCCA is a growing network of independent oncology practices from across the country. NCCA members, through collaboration, sharing of best practices,...
